Innovative Pain Management Neuronoff specializes in neuromodulation devices aimed at treating chronic pain, presenting a direct opportunity for partnerships with pain clinics, hospitals, and rehabilitation centers seeking advanced relief solutions.

Growth and Funding With recent funding of 4.5 million dollars and a total funding of 5 million dollars, Neuronoff is scaling its development efforts, indicating potential for collaboration in clinical trials, device deployment, and commercialization efforts.

Cutting-Edge Technology The company's development of the implant Injectrode device signifies a focus on injectable, minimally invasive treatments, appealing to healthcare providers looking for innovative and less invasive therapies for chronic conditions.

Research Momentum Supported by NIH grants and active in ongoing development, Neuronoff offers opportunities to partner in research, early adoption of new devices, and joint innovation initiatives for neuromodulation technologies.

Target Market Fit Operating in a niche but expanding medical device industry with a specialized focus on neuromodulation and pain management, Neuronoff’s solutions align well with healthcare providers seeking advanced, evidence-based pain treatment options.